Restless Legs Syndrome: all 254 studies

Page 3 of 3. Open to participants first (39), then studies with results posted, then the rest; newest registration first within each.

• Altered Brain GABA and Glutamate in Restless Legs SyndromeCompletedNCT01109537
• 12-Week Efficacy And Safety Of Pregabalin In Treating Restless Legs Syndrome (RLS) SubjectsWithdrawnNCT01061372Phase 3
• New Data Analysis Methods for Actigraphy in Sleep MedicineCompletedNCT00949858
• Restless Legs Syndrome Treatment With Botulinum ToxinCompletedNCT00949806Phase 2
• Exercise Training in Dialysis Patients With Restless Legs Syndrome (RLS)CompletedNCT00942253Phase 2
• Neuraxial Anesthesia and Restless Leg Syndromes in CesareanCompletedNCT00872248Not applicable
• Suggested Immobilization Test (SIT) Test for Early Detection of Restless Legs Syndrome (RLS) Augmentation - Proof of ConceptCompletedNCT00867893
• Efficacy and Safety Study of Aplindore in Patients With Restless Legs SyndromeTerminatedNCT00834327Phase 2
• A Single-Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Ropinirole 0.25 mg Tablets Under Fed ConditionsCompletedNCT00674310Not applicable
• A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Ropinirole 0.25 mg Tablets Und Fasted ConditionsCompletedNCT00673088Not applicable
• Neuroma Injections to Treat Restless Legs Syndrome - RCTStatus unknownNCT00656110Not applicable
• A Study to Evaluate the Efficacy and Safety of Cabergoline Compared With Placebo for the Treatment of RLSCompletedNCT00627003Phase 3
• The Effects of Aplindore on the Treatment of Signs and Symptoms of Restless Legs SyndromeCompletedNCT00626418Phase 2
• A Study to Determine the Efficacy and Safety of Cabergoline for the Treatment of Patients With RLSCompletedNCT00625547Phase 3
• Pregabalin (Lyrica) for the Treatment of Restless Legs SyndromeWithdrawnNCT00584246Phase 4
• Cross-Sectional Study: Prevalence of Restless Legs Syndrome in Patients With Unpleasant Sensations of the LegsCompletedNCT00557258
• Non-interventional Observational Study of Pramipexole in Restless Legs Syndrome: Impact on Quality of LifeCompletedNCT00539461
• ASP8825 - Study in Patients With Restless Legs SyndromeCompletedNCT00530530Phase 2
• Phase 3 Open-label Extension Trial With Rotigotine in Idiopathic Restless Legs Syndrome SubjectsCompletedNCT00498108Phase 3
• Sequential Compression Devices for Treatment of Restless Legs SyndromeCompletedNCT00479531Phase 3
• A Study To Investigate The Effects Of End Stage Renal Disease And Hemodialysis On The Pharmacokinetics Of RopiniroleCompletedNCT00422994Phase 1
• Restless Legs Patient Study On Absorption, Distribution, Metabolism And Excretion Of Ropinirole And The Effect Of FoodCompletedNCT00419692Phase 1
• A 6 Week Trial to Study the Efficacy and Safety of a Starting Dose 0.25 mg Pramipexole (Mirapex) in Patients With RLSCompletedNCT00375284Phase 4
• 12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs SyndromeCompletedNCT00373542Phase 4
• Transdermal Lisuride: a Trial for the Treatment of Patients With Restless Legs Syndrome (RLS)CompletedNCT00367822Phase 3
• A Clinical Research Study Testing Ropinirole Treatment for Restless Legs SyndromeCompletedNCT00363857Phase 3
• Phase IV Trial With Pramipexole to Evaluate Safety and Efficacy in Patients With RLS Associated With Mood DisturbancesCompletedNCT00356096Phase 4
• Long-Term Safety Of Ropinirole XR In Patients With Restless Legs SyndromeCompletedNCT00355641Phase 3
• A Phase IV Trial With Pramipexole to Investigate the Effects on RLS Symptoms and Sleep Disturbance in Patients With RLSCompletedNCT00349531Phase 4
• SWITCH:Restless Legs Patients Switched to Ropinirole From PramipexoleCompletedNCT00344994Phase 4
• RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of RopiniroleCompletedNCT00314860Phase 3
• XP13512 (GSK1838262) Versus Placebo in Patients With Restless Legs Syndrome.CompletedNCT00298623Phase 3
• Efficacy and Safety of Pramipexole (PPX) in Moderate to Severe Idiopathic Restless Legs Syndrome (RLS) PatientsCompletedNCT00275457Phase 3
• A Sleep Lab Trial to Investigate the Efficacy and Safety of Transdermal Rotigotine in Subjects With Idiopathic Restless Legs SyndromeCompletedNCT00275236Phase 3
• An Extension Trial to Investigate Long-Term Treatment With Transdermal Rotigotine in Idiopathic Restless Legs SyndromeCompletedNCT00263068Phase 3
• Restless Legs Syndrome Exercise InterventionStatus unknownNCT00258492Phase 1/2
• A Double Blind Crossover Trial of Levetiracetam (Keppra®) and Placebo in the Treatment of Restless Legs Syndrome (RLS)CompletedNCT00247364Phase 2
• Comprehensive Police Fatigue Management ProgramCompletedNCT00246051Not applicable
• Rotigotine Restless Legs Syndrome Dose Finding TrialCompletedNCT00243217Phase 2
• Dose Finding Study of Pramipexole (Sifrol) in Patients With Idiopathic Restless Legs Syndrome (RLS)CompletedNCT00239486Phase 2
• A Clinical Research Study Evaluating Ropinirole Treatment For Restless Legs Syndrome (RLS)CompletedNCT00225862Phase 3
• Sleep Disorders Management, Health and Safety in PoliceCompletedNCT00207285Not applicable
• Efficacy and Safety Study of Topiramate to Treat Restless Legs SyndromeCompletedNCT00200941Phase 4
• Study of Istradefylline (KW-6002) for the Treatment of Restless Legs SyndromeCompletedNCT00199446Phase 2
• Ropinirole XR (Extended Release) In Patients With Restless Legs SyndromeCompletedNCT00197080Phase 3
• Pramipexole (BI-Sifrol®) Orally Once Daily for 6 Weeks in Patients With Primary Restless Legs SyndromeCompletedNCT00152997Phase 2
• A Study in Patients Suffering From Idiopathic Restless Legs Syndrome Who Responded to a Preceding, 6-month Treatment With Open-label Pramipexole Including Titration (0.125, 0.25, 0.5, 0.75 mg Orally q.n.)CompletedNCT00152958Phase 3
• Assess Efficacy and Safety of the Dopamine Agonist Pramipexole Versus Levodopa / Benserazide (Madopar® DR) in Patients With Restless Legs SyndromeCompletedNCT00144209Phase 3
• Ropinirole Tablets In Young Patients With Restless Legs SyndromeCompletedNCT00140712Phase 1
• Three Different Transdermal Doses of Rotigotine in Subjects With Idiopathic Restless Leg SyndromeCompletedNCT00136045Phase 3
• Four Different Transdermal Doses of Rotigotine in Subjects With Idiopathic Restless Legs SyndromeCompletedNCT00135993Phase 3
• Efficacy and Safety of Pramipexole Compared to Placebo in the Treatment of Restless Legs Syndrome (RLS)CompletedNCT00133198Phase 3
• Relationship Between Sensory and Motor Systems in Restless Leg SyndromeCompletedNCT00074672
• Effect of Ropinirole on Spinal Cord Reflexes and Restless Legs SyndromeCompletedNCT00051961

← Restless Legs Syndrome overview